241 results on '"Ringwald J"'
Search Results
2. Chronic pain in refugees with posttraumatic stress disorder (PTSD): A systematic review on patients' characteristics and specific interventions
3. S3 Guideline: Diagnosis and Therapy of Biliary Carcinoma Short Version 2.00-June 2021, AWMF Register Number: 032-053OL
4. S3-Guideline - Diagnosis and Therapy of Biliary Carcinoma
5. Immature platelets do not reliably predict platelet recovery in patients with intensive chemotherapy or stem cell transplantation
6. S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome
7. S3-Leitlinie – Diagnostik und Therapie biliärer Karzinome
8. Life-Threatening Hemorrhage in a Patient with Red Cell Antibodies — Effective Blood Coagulation with rFVIIa
9. Assessing the need for psychooncological support: screening instruments in combination with patientsʼ subjective evaluation may define psychooncological pathways
10. Moderne Antikoagulation mit Faktor Xa-Inhibitoren in der Onkologie: Ist die gastrointestinale Blutungsrate (mit)-entscheidend?
11. Correlation of the hypotonic shock response and extent of shape change with the new ThromboLUX™
12. Association of blood group A with early-onset ovarian hyperstimulation syndrome
13. The influence of four different anticoagulants on dynamic light scattering of platelets
14. Residual aggregates in platelet products: what do we know?
15. The structure of the von Willebrand factor is not altered in patients with colorectal carcinoma
16. Human platelet antigen genotypes in Turkish and Caucasian blood donors in Germany
17. Precise pH measuring of platelet concentrates containing additive solution – the impact of the temperature
18. IMPACT OF IMMEDIATE OR DELAYED HOLD TIME PRIOR TO PLATELET ADDITIVE SOLUTION ADDITION ON THE IN-VITRO QUALITY OF APHERESIS PLATELETS: 3C-S8–04
19. Transitory interruption of recommended storage conditions does not cause significant changes in in vitro parameters of leucocyte-depleted red blood cells
20. Established ways to keep donorʼs interest alive
21. Evaluation of a new apheresis system for the collection of leukoreduced single donor platelets
22. Preparation of highly concentrated and white cell-poor platelet-rich plasma by plateletpheresis
23. Life-Threatening Hemorrhage in a Patient with Red Cell Antibodies — Effective Blood Coagulation with rFVIIa
24. Why do some apheresis donors donate blood just once?
25. Intrauterine Use of Hyperconcentrated Platelet Concentrates Collected with Trima Accel in a Case of Neonatal Alloimmune Thrombocytopenia: SP271
26. Why Do Some Apheresis Donors Donate Blood Just Once?: SP229
27. Recruitment of Monocyte Subpopulations by Leukocytapheresis in Healthy Blood Donors: SP68
28. Increased frequency of cardioembolism and patent foramen ovale in patients with stroke and a positive travel history suggesting economy class stroke syndrome
29. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies
30. Collection of hyperconcentrated platelets with Trima Accel
31. Washing Platelets With New Additive Solutions—Aspects On The In Vitro Quality After 48 Hours Of Storage: SP146
32. Short-Term Storage Of Platelet Split Products Intended For Neonatal Transfusion: S17-030D
33. Hyperconcentrated platelets stored in additive solution: aspects on productivity and in vitro quality
34. Hepatitis B virus vaccination of blood donors – what costs may be expected?
35. The in vitro quality of washed, prestorage leucocyte-depleted red blood cell concentrates
36. Sample preparation technique and white cell content influence the detectable levels of growth factors in platelet concentrates
37. First comparison of productivity and citrate donor load between the Trima® version 4 (dual-stage filler) and the Trima Accel® (single-stage filler) in the same donors
38. Storage of platelets in additive solutions: a multicentre study of the in vitro effects of potassium and magnesium
39. Storage of Apheresis Platelets in Two New Additive Solutions
40. Apheresis of Immunocompetent Cells: A Paired Study to Compare Two MNC Programs on Two Apheresis Devices
41. Comparison of Productivity and Citrate Donor Load between the Trima Version 4 and the Accel in the Same Donors
42. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)
43. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
44. Determining the need for support: Screening instruments in combination with patients’ subjective evaluation define pathways in psycho-oncology
45. The novel allele,HLA-B*08:113, identified in a German cord blood donor and his mother
46. The novel allele,HLA-DQB1*02:27, identified in a German cord blood donor and his mother
47. Residual aggregates in platelet products: what do we know?
48. Waiting for Platelet Counts Causes Unsubstantiated Delay of Thrombolysis Therapy
49. The novel allele, HLA‐B*07:68:02, identified in a German cord blood donor and her father
50. Neuzeitlicher Schwangerschaftsabbruch: Vitamin-K-Antagonisten?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.